Related by context. All words. (Click for frequent words.) 93 developer Antisoma plc 73 Combination REOLYSIN R 71 PRNewswire FirstCall YM BioSciences 70 Prednisone Against Refractory 70 PRNewswire FirstCall Sanofi aventis 70 NYSE Amex YMI 70 Antisoma plc 70 Æterna Zentaris Inc. 69 & LSE GLPG 69 LSE SHP.L 69 Inc. AMEX YMI 69 Provectus Pharmaceuticals specializes 69 Inc. Nasdaq SUPG 69 Biological Therapy 69 ALLSCHWIL BASEL SWITZERLAND 69 Initiates Enrollment 69 Nasdaq ENZN 69 Initiates Clinical Trial 69 Inc. AMEX LIV 69 Galapagos NV Euronext 69 FOLOTYN ® 69 See BioWorld Today 68 CLAVIS 68 MorphoSys AG FSE MOR 68 Therapeutic Competitors companiesandmarkets.com adEgemonye 68 Evotec AG Frankfurt 68 AMEX RGN 68 Torisel temsirolimus 68 PRNewswire FirstCall AEterna Zentaris 68 NASDAQ CRXL 68 Initiates Phase III 68 Crucell NV NYSE Euronext 68 pralatrexate injection folate analogue 67 OncoGenex Pharmaceuticals Inc. 67 Sanofi aventis EURONEXT SAN 67 IG HCR ;) CO 67 Clavis Pharma ASA OSE 67 Nasdaq FURX 67 Annamycin 67 Inc. NASDAQ SUPG 67 AIM SLN 67 Tykerb lapatinib 67 Inc. NASDAQ SNUS 67 PRNewswire FirstCall SuperGen 67 TRACON Pharmaceuticals 67 NEWTOWN Pa. BUSINESS WIRE 67 Namenda Memantine HCl 67 Inc. Nasdaq INFI 67 TARRYTOWN NY BUSINESS WIRE 67 Brentuximab Vedotin SGN 67 www.ucb group.com 67 Completes Patient Enrollment 67 Novartis VIRT X 67 NASDAQ AEZS 67 Vitrasert R 67 Actelion Ltd 67 Nasdaq ACEL 67 Crucell NV Euronext 67 CNW YM BioSciences 67 Therapeutic Competitors Companies 67 Alternext ALEHT 67 Aegerion Pharmaceuticals Inc. 67 Receives Orphan Drug Designation 67 Galapagos NV Euronext GLPG 67 Inc. TSX AEZ 67 Temsirolimus 67 dasatinib Sprycel 67 Algeta ASA OSE ALGETA 67 Inc. Nasdaq IMGN 67 refractory chronic lymphocytic 67 Inotek Pharmaceuticals Corporation 66 Aphton Corporation 66 Inc. NASDAQ BPAX 66 initiated Phase Ib 66 Abraxis Bioscience Inc. 66 NASDAQ OSIP announced 66 Presents Preclinical 66 Inc. Nasdaq IDMI 66 Inc. NASDAQ AEZS 66 NASDAQ SHPGY 66 Nasdaq CRXL 66 FDA APPROVES 66 Epeius Biotechnologies Corporation 66 Nasdaq KOSP 66 NASDAQ INGN 66 PRNewswire FirstCall Pharmacopeia 66 PRNewswire FirstCall Labopharm 66 PRNewswire FirstCall Cytokinetics Incorporated 66 Inc. NASDAQ AGIX 66 Amex KAL 66 Nexavar sorafenib 66 resistant hormone refractory 66 Nasdaq IMGN 66 Syndax Pharmaceuticals Inc. 66 Company Euronext OCTO 66 humanized therapeutic 66 Tibotec BVBA 66 Hematology Molecular Pathology 66 Inc. Nasdaq PARD 66 Immunotherapeutic 66 Antisoma plc LSE 66 NYSE Amex PTN 66 PF # [002] 66 Initiates Phase II 66 Inc. NASDAQ SCLN 66 NASDAQ ARIA 66 sirtuin inhibitor program 66 Clinical Trials Update 66 progressive metastatic prostate 66 Nasdaq DVAX 66 OTCBB NPHC biotechnology 66 PRNewswire FirstCall QIAGEN NV 66 TKPHF 66 LymphoStat B TM 65 Nasdaq RDEA 65 Nasdaq REGN 65 PRNewswire FirstCall Amarin 65 Memgen 65 Nasdaq AEGR 65 thetreatment 65 NASDAQ INFI 65 Hormone Refractory Prostate Cancer 65 Nasdaq OSIP 65 Inc. Nasdaq IDIX 65 NASDAQ ARRY 65 Nasdaq BCRX 65 Astex Therapeutics 65 Inc. NASDAQ IDIX 65 LungAlert TM 65 Nasdaq INGN 65 Cancer Patients Treated 65 Romidepsin 65 NASDAQ CXSP announced 65 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 65 Phase 2a Trial 65 OTCBB PYTO 65 NASDAQ AVII developer 65 Mg Usa 65 PRNewswire FirstCall Callisto Pharmaceuticals 65 Endo Pharmaceuticals Nasdaq ENDP 65 Nasdaq HALO 65 kidney urologic 65 Nasdaq PGNX 65 hormone refractory metastatic prostate 65 Arimidex anastrozole 65 Insmed Incorporated NASDAQ INSM 65 PRNewswire FirstCall NicOx SA 65 Reminyl galantamine 65 Begins Dosing 65 Durata Therapeutics 65 Nasdaq SNSS 65 TOPIGEN Pharmaceuticals Inc. 65 NASDAQ AVNR 65 CANCER RESEARCH 65 BOTHELL WA Marketwire #/#/# 65 commercialize MDV# 65 Brussels THR 65 NICE Recommends 65 please visit http:/www.vandapharma.com 65 Quark Pharmaceuticals Inc. 65 commercializes oncology 65 non nucleoside inhibitor 65 AAG geldanamycin analog 65 AEterna Zentaris Inc. 65 gets USFDA nod 65 Novel Oral 65 Submits NDA 65 Announces Poster Presentations 65 AVAX Technologies Inc. 65 Modrenal R 65 gastro intestinal inflammation 65 FDA Approves Novel 65 YM AIM YMBA 65 Safinamide 65 Therapeutic Competitors 65 ExonHit Therapeutics SA 65 Inc. Nasdaq COLY 65 Shire plc LSE SHP 65 Initiates Clinical Trials 65 CHESHIRE Conn. BUSINESS WIRE 65 Inc. Nasdaq RDEA 65 ICON plc NASDAQ ICLR 65 PRNewswire FirstCall Rosetta Genomics 65 SWX RO SWX ROG 65 Adjuvant Treatment 64 Nasdaq TARG 64 NASDAQ SCLN 64 midstage clinical 64 Renal Cancer 64 SHP LN 64 NYSE Amex PBTH 64 Corp. Nasdaq BSTC 64 Drug Shows Promise 64 novel immunotherapies 64 dermatology therapies 64 PRNewswire FirstCall Poniard Pharmaceuticals 64 Euronext Paris Code Isin 64 GVAX ® 64 Bevacizumab Avastin 64 b3c newswire 64 Kosan Biosciences Incorporated 64 OTCBB URGP specialty 64 PRNewswire Shire plc 64 Dynepo TM 64 candidates Azedra TM 64 Nasdaq CYTR biopharmaceutical 64 NASDAQ ALTH 64 Roche MabThera 64 OTCBB IMUC 64 Tramiprosate ALZHEMED TM 64 OTC BB PVCT 64 LYON France BUSINESS WIRE 64 Argenta Discovery 64 PRNewswire FirstCall Monogram Biosciences 64 anastrozole Arimidex 64 commercializing oxidized glutathione 64 AB OMXS BINV 64 personalized cellular immunotherapy 64 Inc. Nasdaq AVRX 64 Files IND 64 Frankfurt XMP 64 Inc. OTCBB ALRX 64 BLRX 64 Nasdaq IDIX 64 oncolytic virus therapies 64 SWX ATLN announced 64 HER2 Positive 64 metastatic colorectal 64 Maven Semantic 64 Antibody Therapeutics 64 essential thrombocythemia ET 64 Inc. NASDAQ ALTH 64 GlaxoSmithKline plc GSK 64 evaluating tivozanib 64 Agios Pharmaceuticals 64 gastrointestinal stromal 64 GlaxoSmithKline Tykerb 64 NASDAQ CLSN 64 Nasdaq PCOP 64 MEK Inhibitor 64 CeNeS Pharmaceuticals plc 64 deCODE ProstateCancer TM 64 includes AstraZeneca Accolate 64 Nasdaq GNTA 64 Vidaza azacitidine 64 #/#/# DIAGNOS inc 64 Inc. NASDAQ VSGN 64 Bayer Nexavar 64 Inc. www.micromet inc.com 64 Celsion Corporation 64 Presents Positive 64 J Allergy Clin 64 commercialize deforolimus 64 Atripla combines 64 Ixempra 64 NasdaqGM NTEC today 64 PRNewswire FirstCall Kensey Nash 64 Meets Primary Endpoint 64 cetuximab Erbitux 64 Clavis Pharma ASA 64 Nasdaq PARD 64 Nasdaq ACHN 64 Nasdaq NABI 64 Viagra Soft Cialis Soft 64 pharmacogenomic translational research 64 Phase 2b Clinical Trial 64 Sapacitabine 64 sorafenib tablets 64 PRNewswire FirstCall MannKind 64 thalidomide Thalomid 64 NOVARTIS 64 NYSE PFE Exelon Rivastigmine 64 Vion Pharmaceuticals 64 Nasdaq ONXX 64 Romiplostim 64 brivanib 64 Migenix 64 Auxilium Pharma 64 TSX MGI 64 Temodar ® 64 Nasdaq INCY announced 64 CNS Disorders 64 include ColorectAlert TM 64 FoldRx Pharmaceuticals Inc. 64 AMEX YMI 64 GLOBE NEWSWIRE Achillion Pharmaceuticals 64 NYSE Amex RPC 64 Initiate Clinical Trial 64 Vertex hepatitis C 64 Bayer HealthCare Onyx Pharmaceuticals 64 Nasdaq MITI biopharmaceutical 64 TSX AEZ 64 Synosia Therapeutics 64 Targanta Therapeutics Corporation 64 Submits Biologics License Application 64 Aflibercept 64 PRNewswire FirstCall MIGENIX 64 Slow Progression 64 R lenalidomide 64 Submits Response 64 Inc. OTCBB CYKN 64 Research www. elsevier.com 64 Amex ANX 64 Inc. Nasdaq SEPR 64 MBRX 64 CYT# potent vascular disrupting 64 TELINTRA R 64 Shows Promise Against 64 J Am Acad 64 Nasdaq VRTX 64 investigational oral inhibitor 64 Introgen Therapeutics Inc. 64 Pertuzumab 63 drug Treanda 63 TSX IZP 63 Inc. NASDAQ ANPI 63 NASDAQ OGXI 63 Nasdaq EPCT 63 DEERFIELD Ill. BUSINESS WIRE 63 Hsp# Inhibitor 63 Nasdaq IDRA 63 relapsing remitting MS RRMS 63 5 lipoxygenase activating 63 OTCBB NRGX 63 NASDAQ ONCY 63 Rebif interferon beta 1a 63 approved incretin mimetic 63 Xeloda ® 63 Interferon beta 1a 63 ATRA IV 63 Pharma Merck Serono 63 Pharmion Corporation 63 Agendia BV 63 ® lenalidomide 63 Achieves Primary Endpoint 63 Naive Patients 63 R Saizen R 63 novel VDA molecule 63 Severe Sepsis 63 OTCBB OHRP 63 IAP inhibitor 63 NASDAQ CGEN announced 63 vaccine Synflorix 63 Phase #b/#a clinical 63 AFREZZA TM 63 Nasdaq SPPI 63 ABI OTCBB AMAR 63 NASDAQ IDRA 63 OTCBB HPLF 63 Inc. NASDAQ SPPI 63 CARMIEL Israel 63 Therapeutics TCT scientific 63 Medivation Inc 63 pregabalin Lyrica 63 Nasdaq ACAD 63 Nasdaq CLDX 63 memantine HCl 63 BUFORD Ga. BUSINESS WIRE 63 Elagolix 63 PRNewswire FirstCall Pharmasset 63 BIOGEN IDEC 63 Euronext Paris BIO 63 Receives Milestone Payment 63 Inc. Nasdaq VVUS 63 metastatic androgen independent 63 PRNewswire FirstCall Allos Therapeutics 63 WATERTOWN Mass. BUSINESS WIRE 63 Vernalis plc 63 PRNewswire FirstCall Aeterna Zentaris 63 NASDAQ LGND 63 NASDAQ OMX Nordic ACTI 63 Abstract Accepted 63 THERAPEUTICS 63 Slows Progression 63 VentiRx Pharmaceuticals 63 FORMA Therapeutics 63 Nasdaq ENMD 63 NASDAQ SCRX specialty 63 By JAMAAL ABDUL 63 dasatinib Sprycel ® 63 MIND CTI LTD 63 osteolytic bone disease 63 IL# PE#QQR 63 NASDAQ IMCL 63 INSPIRE Trial Phase III 63 ELADUR ™ 63 Pruvel TM 63 Inc. Nasdaq ANDS 63 Cyclacel Pharmaceuticals 63 NYSE Amex RNN 63 rasagiline tablets 63 GILD GILD 63 Rheumatoid Arthritis Drug 63 Vaccine Adjuvant 63 NASDAQ CORT 63 NASDAQ CLDX 63 Prodarsan R 63 Tesmilifene 63 Inc. NASDAQ TRMS 63 OSI Tarceva 63 Prana Biotechnology Limited 63 Inc. Nasdaq ALSE 63 AstraZeneca AZN.L 行情 63 compound perifosine 63 ThermoDox R 63 Ohr Pharmaceutical Inc. 63 NASDAQ PCYC 63 #/#/# SciClone Pharmaceuticals 63 MPH AMEX 63 Oncolytics TSX ONC 63 EURONEXT SAN 63 PRNewswire FirstCall Regeneron Pharmaceuticals 63 Bucindolol 63 FDA Approves Generic 63 Nasdaq ALNY 63 NYSE Amex HEB 63 Novartis Femara 63 Alnylam Nasdaq ALNY 63 Nasdaq CYCC 63 targeted immunotherapies 63 MKC# MKC# PP 63 NASDAQ IMMU 63 PRNewswire FirstCall Neurogen 63 Am J Obstet 63 plc LSE SHP 63 Personalized Immunotherapy 63 accumulate preferentially 63 By JENNIFER LEARN 63 Treatment Shows Promise 63 HepaLife Technologies Inc. 63 Urigen Pharmaceuticals Inc. 63 Enzon Pharmaceuticals Inc 63 Sutent sunitinib malate 63 DEERFIELD Ill. Business Wire 63 BRANFORD Conn. BUSINESS WIRE 63 Inc. Nasdaq AGIX 63 tin ib targets 63 Fresenius Biotech 63 Transdermal Patch 63 Newly Diagnosed Patients 63 Inc. Nasdaq TPTX 63 OTCBB INSV 63 SIX RO ROG 63 label Lipofen R 63 CIMZIA r 63 NicVAX TM 63 treat nicotine addiction 63 Advanced Melanoma 63 Ltd. OTCBB IMUC 63 TO AVOID PREGNANCY WHILE 63 phase IIb trial 63 Granted Orphan Drug 63 HCV NS5B polymerase 63 GNSZ 63 SCIB1 63 Nasdaq XTLB 63 Nasdaq IDRA today 63 Kinase Inhibitor 63 GW# [003] 63 Peginterferon alfa 2b 63 Presents Positive Preclinical 63 GLOBE NEWSWIRE LeMaitre Vascular 63 Gonal f R follitropin 63 Tumour Vascular Disrupting Agent 63 BioSante Pharmaceuticals Announces 63 Eribulin 63 Plc SHP LN 63 NASDAQ SOMX specialty 63 PRNewswire FirstCall Idenix Pharmaceuticals 63 IN PATIENTS WITH 63 Genaera Corporation 63 Reports Preclinical Data 63 OncoVex 63 Mylan Receives Approval 63 Inc. Amex VRA 63 SOPHIA ANTIPOLIS France 63 VANTAS ® 63 liposomal delivery 63 Asthma COPD 63 EXTON Pa. BUSINESS WIRE 63 PRNewswire FirstCall VIVUS 63 Inc. Nasdaq CRTX 63 nasal calcitonin product 63 NASDAQ PANC 63 Crofelemer budesonide foam 63 PRAECIS PHARMACEUTICALS INCORPORATED 63 Inc. NASDAQ HEPH 63 Oncothyreon NASDAQ ONTY 63 Biomarker Study 63 Inc. NASDAQ MRNA 63 Inc. Nasdaq ALTH 63 Azacitidine 63 Application MAA 63 DVT prophylaxis cholesterol 63 Inc. Nasdaq MITI 63 Acorda Therapeutics Inc 63 Nasdaq INCY 63 Nasdaq ISTA 63 MEDAREX 63 Nasdaq KOSN 63 Crucell NV NASDAQ CRXL 63 Nasdaq PPHM clinical 63 PRNewswire FirstCall ACCESS PHARMACEUTICALS 63 vinorelbine tartrate 63 PAION AG ISIN 63 Vidaza R 63 Multiple Sclerosis Rheumatoid Arthritis 63 REGENERX BIOPHARMACEUTICALS INC. 63 Inc. NASDAQ BIOC 62 Completes Patient Enrolment 62 PRNewswire FirstCall PAREXEL 62 Metabasis Therapeutics Inc. 62 PRNewswire FirstCall Genaera 62 Corp. NASDAQ PSDV 62 GLOBE NEWSWIRE Emisphere Technologies 62 Inc. NASDAQ ORXE 62 R sorafenib tablets 62 ® darbepoetin alfa 62 Taxotere docetaxel 62 RANK Ligand inhibitor 62 Conatus Pharmaceuticals 62 Nasdaq KERX 62 PRNewswire FirstCall Palatin Technologies 62 Stock Exchange EVT 62 pharma.com 62 Complicated Skin 62 Erbitux cetuximab 62 Nasdaq PHRM 62 nilotinib Tasigna 62 AMEX KAL 62 Dexilant 62 Nasdaq PPHM 62 Pepscan Therapeutics 62 ovarian prostate 62 Xanthus Pharmaceuticals Inc. 62 Oral Fingolimod 62 Nasdaq THLD 62 TRANSDUR ® 62 Inc. NASDAQ QLTI 62 NASDAQ AEZS TSX AEZ 62 OTCBB NVLT biopharmaceutical 62 Javelin Pharmaceuticals AMEX JAV 62 Corporation Nasdaq MNKD 62 Marillion Pharmaceuticals 62 Nasdaq NPSP 62 SinuNase ™ 62 YM BioSciences Inc. 62 Inc. Nasdaq MDVN 62 Hematological Malignancies 62 NASDAQ PGNX 62 Drug Candidate 62 Plenaxis 62 Amira Pharmaceuticals 62 metastatic castrate resistant 62 Quark Pharmaceuticals 62 Hedgehog Pathway 62 NASDAQ ABII 62 Immunomedics Inc. 62 Nasdaq IMMU 62 Neoadjuvant 62 Napo Pharmaceuticals 62 Onyx Pharmaceuticals Inc 62 Patients Treated With 62 PRNewswire FirstCall Nektar Therapeutics 62 Inc. Nasdaq RNVS 62 Vaccine Protects Against 62 Callisto Pharmaceuticals Inc. 62 rALLy clinical trial 62 Oxford BioMedica LSE OXB 62 Arzerra ofatumumab 62 Alnylam Pharma 62 ImClone Systems Incorporated 62 PRNewswire FirstCall Cell Genesys 62 Nasdaq PRAN 62 Neulasta R 62 Inc. Nasdaq ATHX 62 cetuximab Erbitux R 62 cause mesothelioma asbestosis 62 antibody MAb 62 ChemGenex Pharmaceuticals Limited 62 Antisoma AS# 62 Nasdaq CGEN 62 LSE SHP 62 adalimumab Humira 62 OTCBB TDLP 62 induced macular edema 62 NASDAQ WCRX 62 ESBATech AG 62 GLAXOSMITHKLINE 62 myelodysplastic myeloproliferative diseases 62 Arpida SWX ARPN 62 Response Genetics Inc. 62 Intravenous CP 62 Cancer Incidence Mortality 62 NASDAQ CYTK announced 62 NYSE Amex RGN 62 PLX MS 62 Fulvestrant 62 Sprycel dasatinib 62 HCV polymerase 62 NASDAQ SCRX 62 GLOBE NEWSWIRE Nabi Biopharmaceuticals 62 Cadence Pharmaceuticals Inc 62 liver resection surgeries 62 Nasdaq QGEN 62 virus HCV protease inhibitor 62 PRNewswire FirstCall Shire plc 62 methylnaltrexone bromide 62 Nicotine Vaccine 62 Inc. Nasdaq REGN 62 SIX ATLN 62 Isis Pharma 62 Ceragenix Pharmaceuticals Inc. 62 NASDAQ IMCL global 62 histone deacetylase HDAC inhibitor 62 VitiGam 62 Nasdaq ETWC leading 62 Inc. Lorus biopharmaceutical 62 AVASTIN 62 SWX ATLN 62 LEXINGTON Mass. BUSINESS WIRE 62 Ceflatonin R 62 interferon beta 1a infertility 62 Trandolapril 62 related CMV Retinitis 62 EOS NASDAQ MELA 62 Zorbtive TM 62 investigational immunotherapy 62 Etravirine 62 Known generically 62 Onglyza saxagliptin 62 NASDAQ DCTH 62 SkyePharma Plc 62 Corporation Nasdaq KNSY 62 NeurAxon Inc. 62 PNP inhibitor 62 Malignant Melanoma 62 neovascular age 62 Nasdaq PGNX today 62 Receives Approvable Letter 62 vapreotide acetate 62 Drug Fails 62 Febuxostat 62 mitoxantrone plus 62 ZEVALIN ® 62 Pivotal Clinical Trial 62 Revlimid lenalidomide 62 NasdaqCM PSTI DAX PJT 62 RNVS 62 Nasdaq AMGN 62 BNVID 62 Corporation Nasdaq CRGN 62 Taiho Pharmaceutical 62 Combivir Kivexa 62 Nasdaq MBRX 62 PRNewswire FirstCall Oncothyreon 62 NASDAQ CGEN 62 NASDAQ ISTA 62 ReGen Therapeutics Plc 62 Nasdaq ALXN 62 Degarelix 62 Epiphany Biosciences 62 PRNewswire FirstCall Northwest Biotherapeutics 62 DG# compounds targeting 62 YONDELIS R 62 Nasdaq DEPO 62 Telik logo TELINTRA 62 Amgen Neulasta R 62 Inc. NASDAQ CBST 62 Wyeth Torisel 62 AVANIR Pharmaceuticals Inc. 62 Nasdaq EXAS today 62 Initiates Clinical 62 Clinical Trial Investigating REOLYSIN 62 PRNewswire FirstCall Alfacell Corporation 62 Prolongs Survival 62 Arpida Ltd. 62 PRNewswire FirstCall Bionovo 62 Corporation Nasdaq GENR 62 PRNewswire FirstCall Oncolytics Biotech 62 AMEX IMM 62 OTCBB EMIS 62 TRANSDUR ™ 62 rivastigmine Exelon 62 OTCBB VCRT 62 PharmaVitae Profile 62 Quinamed 62 lexidronam injection 62 #-# Full Text 62 NASDAQ CYTX 62 please visit http:/www.atherogenics.com 62 PRNewswire FirstCall Coley Pharmaceutical 62 Inc. Nasdaq KERX 62 metastatic renal cell 62 TSX VIR 62 Vandetanib 62 NYSE AMEX PLX 62 MKC# MT 62 metastatic castration resistant 62 Monoclonal antibody 62 Patient Enrollment 62 Onko Sure TM 62 BioSyent TSX VENTURE 62 PRNewswire FirstCall Genta Incorporated 62 Allovectin 7 62 Nasdaq BSTE 62 Basilea Toctino R 62 Initiates Phase 2b 62 Completes Dosing 62 Cotara ® 62 Nasdaq AUXL 62 AS# amonafide L malate 62 OctoPlus NV OctoPlus 62 Inc. Nasdaq IMMU 62 NASDAQ BTRX pharmaceutical 62 Raptiva R 62 PFE PFE 62 Demonstrates Significant 62 Vicriviroc 62 Aerie Pharmaceuticals 62 acadesine 62 SPL# Gel vaginal microbicide 62 Daclizumab 62 OXBT 62 Bioenvision Nasdaq BIVN 62 Kosan dependence 62 AstraZeneca Iressa 62 Javelin Pharmaceuticals Inc 62 ImmunoGen Inc. 62 ImmunoCellular Therapeutics Ltd. 62 intrahepatic bile duct 62 Glaxo Tykerb 62 Inc. NASDAQ CLDA 62 RhuDex TM 62 Liestal Switzerland 62 Platinum Resistant Ovarian 62 Nasdaq IVGN 62 ViroPharma Incorporated Nasdaq VPHM 62 orally inhaled migraine 62 MAGE A3 ASCI 62 metastatic hormone refractory 62 InfuSystem Holdings Inc. 62 Medivir AB 62 EnteroMedics proprietary neuroblocking technology 62 Regeneron Pharma 62 Inc. Nasdaq PPHM 62 Cypress Bioscience Inc 62 PRNewswire FirstCall Isis Pharmaceuticals 62 PRNewswire Anthera Pharmaceuticals 62 AstraZeneca Plc AZN LN 62 AVXL 62 VIVITROL ® 62 PRNewswire FirstCall Peregrine Pharmaceuticals 62 Inc. Nasdaq ELGX 62 Nasdaq AEZS 62 Inc. Nasdaq SGXP 62 NASDAQ INHX 62 Advancis Pharmaceutical Corporation 62 Hedgehog Pathway Inhibitor 62 Mg Uk 62 brand ciclesonide HFA 62 EPIX Pharmaceuticals Inc. 62 TSRX 62 Treatment Reduces 62 Successfully Treats 62 efaproxiral 62 Gemzar gemcitabine 62 TSX YM AIM 61 Corporation NASDAQ MNKD 61 Merrion Pharmaceuticals 61 antibody trastuzumab 61 BiTE R 61 Diasome Pharmaceuticals 61 PRNewswire FirstCall Sunesis Pharmaceuticals 61 NASDAQ CRTX 61 OTCBB ILNS 61 Nutra Pharma wholly owned 61 Acceleron Pharma Inc. 61 NASDAQ NKTR 61 Velcade bortezomib 61 PRNewswire FirstCall Vical Incorporated 61 Investigational Treatment 61 J Clin Endocrinol Metab 61 Inc. Nasdaq CEGE 61 LENALIDOMIDE 61 Node Positive 61 Lymphocytic 61 Serdolect ® 61 Critical Therapeutics Zyflo 61 Canvaxin 61 PRNewswire FirstCall Indevus Pharmaceuticals 61 Vaccine Immunology 61 recurrent glioblastoma multiforme 61 Initiate Phase 61 Eurand NV EURX 61 TSX DND 61 phase III isavuconazole 61 PRNewswire FirstCall Micromet 61 Initiates Dosing 61 OMP #R# 61 AMEX NVD specialty 61 PRNewswire FirstCall Emisphere Technologies 61 BSX COV leading 61 Therapeutic Approaches 61 Idenix Pharma 61 Gleevec imatinib mesylate 61 AMEX RGN www.regenerx.com 61 Cutaneous T 61 receptor modulators 61 Proc Am Soc 61 Pirespa 61 KuDOS 61 Removab 61 Serostim ® 61 hematological cancers notably 61 Nasdaq EXAS 61 Alzheimer disease cognitive impairment 61 Inc. OTCBB MBCI 61 Kit CD# positive 61 Announcement acc 61 PRN FDA Approves 61 Ascenta Therapeutics 61 Inc. NASDAQ SGEN 61 NASDAQ BIIB 61 CAMBRIDGE MA USA 61 Monopril 61 NASDAQ SLXP 61 ® bortezomib 61 OTCBB NPHC 61 ALSO CALLED 61 Merck KGaA Erbitux 61 OTCBB IMNR 61 Nasdaq AVAN 61 Mesoblast Limited ASX MSB 61 developing Bicifadine serotonin 61 PRNewswire FirstCall Angiotech Pharmaceuticals 61 PRNewswire FirstCall Pressure BioSciences 61 ACOMPLIA R 61 TNFerade TM 61 Selective Electrochemical Tumor Ablation 61 About Positron Positron 61 ALTROPANE R 61 ASX PGL 61 Nasdaq ALTH 61 Irinotecan 61 protein tyrosine phosphatase 1B 61 Cloretazine ® 61 Receives Positive Opinion 61 Liprotamase 61 NASDAQ ENMD 61 PRNewswire FirstCall Wyeth Pharmaceuticals 61 Xeloda capecitabine 61 Dynavax Technologies Corporation 61 Locked Nucleic Acid 61 Nasdaq RGDX 61 Alemtuzumab 61 BIOPHARMA 61 BIIB.O Quote Profile Research 61 ASONEP TM 61 NASDAQ EPIX 61 BCIRG 61 Relapsed Refractory 61 Electronic Brachytherapy System 61 Nasdaq PSTI 61 telomerase therapeutic 61 Deforolimus 61 NASDAQ ONXX 61 ViroChem Pharma Inc. 61 Eloxatin oxaliplatin 61 Inc. Nasdaq TNGN 61 Vertex Pharmaceuticals NASDAQ VRTX 61 Inc. NASDAQ ACUS 61 Bazedoxifene 61 Psoriasis Drug 61 Adventrx Pharmaceuticals 61 PHASE III 61 NASDAQ FLML 61 PRNewswire FirstCall Favrille 61 drug GAP #B# 61 Adrenomyeloneuropathy AMN HIV 61 NASDAQ NYMX 61 PRNewswire FirstCall BioCryst Pharmaceuticals 61 Inc. Nasdaq RDYN 61 RNAi Therapeutic 61 Inc Therapeutic Competitors 61 Nasdaq ALXA 61 Investigational Oral 61 NASDAQ PRAN ASX PBT 61 metaglidasen 61 Frazer Penn. based 61 dihydrochloride Tablets 61 ribonucleotide reductase clinically validated 61 Obstructive Pulmonary Disease 61 combines bupropion 61 NASDAQ OSIR 61 Adherex Technologies Inc. 61 AMEX DDD 61 4SC AG ISIN DE# 61 Barrier Therapeutics Inc. 61 Nasdaq AMLN 61 SPRYCEL ® 61 Xoma Ltd 61 Nasdaq NPSP announced 61 Corporation Nasdaq GNBT 61 AVEO Pharmaceuticals 61 Phase III Clinical Trial 61 Plethora Solutions Holdings 61 Avanir Pharmaceuticals Inc 61 Inc. Nasdaq ONXX 61 targeted radiotherapeutic 61 Cholesterol lowering statin 61 Myocet 61 Alnara Pharmaceuticals 61 OTCQX RHHBY 61 Nasdaq LXRX 61 Melior Discovery 61 Inc. Nasdaq AMLN 61 NASDAQ IDEV 61 MGI PHARMA INC. 61 AGI Therapeutics 61 Protherics PLC 61 including eniluracil ADH 61 SUTENT ® 61 Pegloticase 61 oropharyngeal candidiasis OPC 61 Bone Marrow Transplants 61 IgG1 monoclonal antibody 61 Emisphere Technologies 61 Nasdaq VRTX today 61 Tezampanel 61 investigational oral hepatitis C 61 Onyx Pharmaceuticals Announces 61 PKC# 61 David W. Gryska 61 Arch Neurol 61 AMEX REX 61 Alimta pemetrexed 61 TSX VENTURE IGX OTCBB 61 TSX TLN 61 Anti VEGF 61 Inc. Nasdaq BIOD 61 Previously Treated 61 Lung Cancer Drug 61 cytomegalovirus immune globulin 61 SWISS BSLN 61 PRNewswire FirstCall Nastech Pharmaceutical 61 Tranzyme Pharma 61 Silodosin 61 Albugon 61 Inc. Nasdaq ANTH 61 Teikoku Pharma USA 61 NYSE Amex AEN 61 GSK.L 61 Preclinical Study 61 Oxford Genome Sciences 61 NASDAQ SHPGY TSX SHQ 61 CLINICAL TRIALS 61 ROCKVILLE Md. Business Wire 61 CRYO 61 ONCY 61 Inc. Nasdaq INSM 61 Hepatocellular Carcinoma HCC 61 Phase IIb Trial 61 Inc. ProMetic www.prometic.com 61 PHARMACEUTICALS 61 PRNewswire FirstCall Ventiv Health 61 Patient Enrolment 61 Femara letrozole 61 includes Dideco CarboMedics 61 MEDA AB publ 61 Ligand Pharmaceuticals Incorporated 61 PRNewswire FirstCall Anadys Pharmaceuticals 61 TSX TKM 61 Inc. Nasdaq LXRX 61 assessing T DM1 61 Announces Tentative Approval 61 Tibotec Pharmaceuticals Ltd. 61 NASDAQ ISIS 61 OTC ACCP 61 Inc. OTCBB SPRX 61 PRNewswire FirstCall DURECT Corporation 61 Nasdaq OSCI 61 Successfully Completes Phase 61 Othera Pharmaceuticals Inc. 61 Institute DFCI 61 YONDELIS 61 Avila Therapeutics 61 Martinsried Germany 61 OMRIX Biopharmaceuticals 61 Philadelphia Chromosome Positive 61 Symposium SABCS 61 Drug Pipeline 61 Statin Drugs 61 Mepact 61 NASDAQ LIPD 61 IMiDs R 61 Completes Enrollment 61 TSX BRA 61 untreated metastatic pancreatic